TNF and inflammatory bowel disease: Infliximab (IFX), a chimeric monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), has been verified as an effective therapeutic medicine for inflammatory bowel disease (IBD) [1, 2].